Hangzhou Haoyue Personal Care Co., Ltd (605009.SS): BCG Matrix [Apr-2026 Updated]

Hangzhou Haoyue sits at a pivotal inflection: high-growth Stars like adult incontinence, international OEM/ODM and pet hygiene are driving expansion and deserve sustained capex to capture aging, export and pet-trend tailwinds, while cash-generating baby diapers and feminine care fund that push; Question Marks - notably its self-owned brand rollout and the Sibao Care deal - demand careful marketing and integration investment to convert into future stars, and Dogs such as basic wet wipes and legacy low-tech lines signal candidates for divestment or repurposing to free resources for higher-return opportunities.

Hangzhou Haoyue Personal Care Co., Ltd (605009.SS) - BCG Matrix Analysis: Stars

Stars - high-growth, high-share business units driving Haoyue's strategic expansion and margin improvement.

Adult incontinence products: high market growth driven by aging demographics. Global adult diaper market projected to reach USD 17.5 billion by 2034, growing at a 7.1% CAGR (Dec 2025). Haoyue has allocated 25% of its 67 billion-piece annual production capacity (16.75 billion pieces) to adult care. Domestic demand is concentrated in China where the population aged 65+ exceeded 200 million as of 2025, creating a localized boom. Operating margins for adult care products are consistently higher than infant categories, supported by 180+ patents and advanced ZUIKO automated production lines. Capital expenditure remains focused on adult care capacity expansion and brand development to shift from OEM to Haoyue-branded, higher-margin products.

International OEM/ODM services: a high-growth engine with dominant regional presence. Haoyue holds a 12% market share in Southeast Asia (late 2025) and is a core supplier for major maternal and child brands in Indonesia and Vietnam. Export-led revenues rose 32.43% YoY to CNY 3.61 billion in the last twelve months. Six global manufacturing bases and 400,000 sqm of factory space support scale economics and a 27.9% gross margin. Strategic partnerships with multinational giants such as Kimberly-Clark and P&G provide stable procurement contracts and ramping volumes in emerging markets. Logistics efficiency (15-day delivery for a 40HQ container) compresses working capital and improves asset turns.

Pet hygiene products: emerging Star with differentiated absorbent technology and premium positioning. China's pet products market projected to reach CNY 48.4 billion by 2025, with pet diapers growing at a 13.6% CAGR. Haoyue has redeployed absorbent SAP and manufacturing know-how into pet diapers, increasing non-infant revenue share (internal mid-2025 estimate: 8-12% of non-infant sales). Consumer demographics favor premiumization: 60% of pet owners are post-90s/post-00s, prioritizing premium and sustainable products. Investment in plant-based SAP aligns with eco-conscious demand and positions pet hygiene as a high-growth, low-competition Star segment within the portfolio.

• Capacity & CAPEX: prioritize automation and capacity split (16.75B adult allocation) to capture aging demographic demand.
• Brand transition: accelerate shift from OEM to Haoyue self-owned brands to realize higher gross and operating margins.
• International scale: expand SEA footprint and optimize 15-day logistics to sustain 27.9% gross margin on exports.
• Product innovation: invest in plant-based SAP and recyclable materials for pet and adult products to meet eco-conscious trends.
• IP & automation leverage: monetize 180+ patents and ZUIKO lines to maintain cost leadership and product quality.

Hangzhou Haoyue Personal Care Co., Ltd (605009.SS) - BCG Matrix Analysis: Cash Cows

Cash Cows

Baby diapers remain the primary revenue anchor despite a maturing domestic market. This segment accounts for over 70% of Haoyue's total revenue as of December 2025, providing consistent cash flow to fund expansion and acquisitions. Key quantitative metrics for the baby diaper business: over 70% revenue share, 6.7 billion piece annual capacity, 60% of that capacity dedicated to infant hygiene (4.02 billion pieces), a domestic Asia Pacific market share of 34.4% via strategic retail partnerships (e.g., Kids King), an 8.2% net margin and an 11.7% return on equity attributable largely to high-volume manufacturing efficiencies.

The domestic baby diaper market faces headwinds from a declining birth rate; growth in the global diaper market remains steady at a 7.3% CAGR while the Chinese market shows stagnation or slight contraction. Haoyue's strategy emphasizes market share retention and margin protection rather than volume-driven expansion in China. The high utilization of existing capacity and scale-driven cost-per-piece reductions preserve profitability despite unit volume pressures.

• Capacity utilization: 6.7 billion pieces total capacity with infant hygiene at ~60% (4.02 billion pieces).
• Revenue concentration risk: >70% of consolidated revenue from baby diapers as of Dec 2025.
• Margin profile: 8.2% net margin corporate figure heavily supported by diaper business; segment-level operating margins near 10%-12% for diapers.
• Market exposure: 34.4% Asia Pacific segment share through anchor retail partnerships (Kids King), limiting customer concentration risk.
• Cash generation: core source for funding acquisitions (e.g., 260 million yuan Sibao Care) and capex-light expansion into adjacent categories.

Feminine hygiene products provide stable returns within a mature and competitive landscape. The segment contributes approximately 15% of the company's total production volume and delivers consistent 15.7% operating margins. The market in 2025 is crowded with domestic and international competitors, but demand is steady. Haoyue leverages its automated production infrastructure to produce sanitary napkins and menstrual pants without major incremental CAPEX, allowing this segment to function as a high-margin, low-investment cash generator that supports strategic premiumization (ultra-thin designs) and acquisition financing.

Cash flow allocation and use:

• Operational cash from diapers funds working capital, routine capex, and acquisitions (260 million yuan Sibao Care acquisition financed in part by segment cash flow).
• Feminine hygiene surplus supports R&D for premium SKUs and branding, requiring minimal line retooling.
• Combination of segments maintains liquidity ratios and provides a buffer against cyclical demand shocks in domestic infant care markets.

Hangzhou Haoyue Personal Care Co., Ltd (605009.SS) - BCG Matrix Analysis: Question Marks

Dogs - Question Marks

Self-owned brand development represents a high-risk, high-reward initiative as Haoyue shifts from OEM dependence toward branded product penetration. Total revenue reached 3.61 billion CNY in late 2025, while the majority of this revenue continues to derive from OEM contracts; self-owned brands therefore show a low relative market share despite being positioned in a market with moderate-to-low growth rates for many product segments.

Marketing and brand-building expenditures for independent labels have increased materially in 2024-2025. Haoyue reported an increase in selling and marketing spend (company disclosure: material increase vs prior year), and consolidated net income declined by 11.65% year-on-year for the 2024-2025 period, reflecting margin pressure from elevated marketing investments and promotional discounts required to acquire shelf space and consumer trial versus entrenched incumbents such as Hengan International.

Key challenges for these Question Mark brands include low relative market share, intense competition, and uncertain ROI as brand investments are balanced against dividend commitments and OEM revenue stability.

The acquisition of Sibao Care is a targeted but risky move to gain instant access to branded feminine care SKUs. Haoyue reduced the transaction price from 360 million CNY to 260 million CNY in December 2025 citing weaker market conditions and underperformance, signaling integration and turnaround risks. Sibao Care contributes the 'Jieting' and 'Quanyinai' brands to Haoyue's portfolio, but current market growth for these brands is sluggish and their current market positioning is weak against domestic leaders such as Baiya Shares.

Strategic levers and constraints for converting Question Marks into Stars or at least Cash Cows:

• Leverage 150+ patents to create differentiated product claims (ingredient/comfort/absorbency innovations) to justify premium pricing and margin expansion.
• Optimize marketing ROI by reallocating spend from broad awareness to targeted digital acquisition and category shopper activation to reduce CAC and accelerate trial-to-repeat rates.
• Integrate Sibao Care SKUs into Haoyue's supply chain to realize cost synergies and reduce COGS for margin improvement.
• Monitor cash flow impact of brand investments against the 8.5 CNY per 10 shares dividend commitment to avoid liquidity strain.
• Prioritize capital allocation: cease or scale back underperforming SKUs and concentrate investment on one or two core self-owned brands with early traction.

Operational and market risks specific to these Question Marks include: ongoing dominance of incumbent national players (e.g., Hengan, Baiya), channel access limitations in modern trade, slower category growth in female hygiene subsegments, and potential further impairment or writedown risk if Sibao Care brands fail to show recovery within a defined integration period (12-24 months).

Relevant short-term performance indicators to track progress:

• Self-owned brand revenue growth rate (monthly/quarterly cadence).
• Gross margin differential: self-owned brands vs OEM products.
• Marketing spend as % of self-owned brand revenue and CAC.
• Repeat purchase rate and 3-6 month cohort retention for new brands.
• Integration cost realization from Sibao Care (target synergy capture, CNY).

Hangzhou Haoyue Personal Care Co., Ltd (605009.SS) - BCG Matrix Analysis: Dogs

Question Marks - Dogs: Traditional non-absorbent hygiene products such as basic wet wipes operate as low-margin, highly contested SKUs within Haoyue's portfolio. As of FY2024-2025 internal estimates, wet wipes represent approximately 6.5% of consolidated revenue but only ~1.8% of net profit, down from 3.2% profit contribution in 2021. Market-level annual growth for basic wet wipes has decelerated to ~1.5% CAGR (2022-2025) while gross margins for the segment have compressed to 8-10% due to sustained price competition and raw material cost volatility.

These products face the following structural constraints:

• High market fragmentation: top 5 players account for ~28% share in China basic wet wipes (2025).
• Low entry barriers: private-label and regional manufacturers increase SKU proliferation.
• Price elasticity: frequent promotional pricing reduces SKU-level ROI by an estimated 150-250 bps vs. company average.
• Operational oversight burden: supply chain and quality monitoring consume ~2-3% of corporate OPEX allocation despite low revenue contribution.

Haoyue's R&D pivot-specifically the degradable membrane initiative-is a tactical attempt to arrest share loss and address sustainability-led demand. Pilots initiated in 2023-2024 increased price realization potential by an estimated 60-120 bps in test channels, but commercial scalability requires incremental CAPEX and retooling estimated at RMB 45-70 million per production line, a low CAPEX priority versus adult incontinence and premium baby care lines.

Legacy low‑tech manufacturing lines for basic paper diapers are another subscale, low-return asset class. In FY2025 these legacy lines accounted for ~4.0% of group revenue, with utilization rates averaging 58% and EBITDA margins near break-even (0-2%). The absence of Haoyue's 'high-multiple water-locking core structure' patents in these SKUs explains weaker consumer pull and limited pricing power.

• Utilization: ~58% average on legacy diaper lines (2025).
• EBITDA margin: ~0-2% for basic paper diaper SKUs.
• Customer complaints: near-zero major complaints but low NPS and weak repurchase rates.
• Maintenance vs. revenue: annual maintenance and compliance costs estimated at RMB 3-5 million per older line, often exceeding incremental net contribution.

Strategic implications for these 'Dogs' within the BCG context include resource-light management, selective divestiture or conversion, and focused pilots (e.g., degradable membranes, line retrofits). Priority allocation data (2025 internal planning) indicates CAPEX share to legacy/basic non-absorbent segments at ~4-6% of total CAPEX, while core absorbent and adult care receive >75% of capital allocation.